Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study.

Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, Lewis J, Rocco M, Toto R, Windus D, Ornt D, Levey AS; HEMO Study Group.

Kidney Int. 2004 Jun;65(6):2380-9.

2.

Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study.

Delmez JA, Yan G, Bailey J, Beck GJ, Beddhu S, Cheung AK, Kaysen GA, Levey AS, Sarnak MJ, Schwab SJ; Hemodialysis (HEMO) Study Group.

Am J Kidney Dis. 2006 Jan;47(1):131-8.

PMID:
16377394
3.

Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study.

Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G.

J Am Soc Nephrol. 2003 Dec;14(12):3251-63.

4.

The association of mental health over time with cardiac outcomes in HEMO study patients.

Kang EW, Pike F, Ramer S, Abdel-Kader K, Myaskovsky L, Dew MA, Unruh M.

Clin J Am Soc Nephrol. 2012 Jun;7(6):957-64. doi: 10.2215/CJN.06730711. Epub 2012 Apr 5.

5.

Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients.

Cheung AK, Greene T, Leypoldt JK, Yan G, Allon M, Delmez J, Levey AS, Levin NW, Rocco MV, Schulman G, Eknoyan G; HEMO Study Group.

Clin J Am Soc Nephrol. 2008 Jan;3(1):69-77. Epub 2007 Dec 5.

6.

[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].

Antonucci F, Camerin E, Feriani M, Nordio M, Piccoli A, Rossi B, Tessitore N.

G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56. Italian.

PMID:
19927265
7.

The HEMO study - where do we go from here?

Himmelfarb J.

Curr Opin Nephrol Hypertens. 2003 Nov;12(6):587-91. Review.

PMID:
14564194
8.

Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) Study.

Ng YH, Meyer KB, Kusek JW, Yan G, Rocco MV, Kimmel PL, Benz RL, Beddhu S, Dwyer JT, Toto RD, Eknoyan G, Unruh ML.

Am J Kidney Dis. 2006 Apr;47(4):614-24.

PMID:
16564939
9.

Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline.

Slinin Y, Greer N, Ishani A, MacDonald R, Olson C, Rutks I, Wilt TJ.

Am J Kidney Dis. 2015 Nov;66(5):823-36. doi: 10.1053/j.ajkd.2014.11.031. Review.

PMID:
26498415
10.

Peripheral vascular disease severity impacts health outcomes and health-related quality of life in maintenance hemodialysis patients in the HEMO Study.

Liu T, Liang KV, Rosenbaum A, Stephenson R, Pike F, Weissfeld L, Unruh ML.

Nephrol Dial Transplant. 2012 Jul;27(7):2929-36. doi: 10.1093/ndt/gfr760. Epub 2012 Jan 23.

PMID:
22273665
12.

Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study.

Iliou MC, Fumeron C, Benoit MO, Tuppin P, Calonge VM, Moatti N, Buisson C, Jacquot C.

Am J Kidney Dis. 2003 Sep;42(3):513-23.

PMID:
12955679
13.

Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the Hemodialysis (HEMO) Study.

Burrowes JD, Larive B, Chertow GM, Cockram DB, Dwyer JT, Greene T, Kusek JW, Leung J, Rocco MV; Hemodialysis (HEMO) Study Group.

Nephrol Dial Transplant. 2005 Dec;20(12):2765-74. Epub 2005 Oct 4.

PMID:
16204298
14.

β-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study.

Tangri N, Shastri S, Tighiouart H, Beck GJ, Cheung AK, Eknoyan G, Sarnak MJ.

Am J Kidney Dis. 2011 Dec;58(6):939-45. doi: 10.1053/j.ajkd.2011.06.024. Epub 2011 Aug 27.

PMID:
21872979
15.

Changes in anthropometry and mortality in maintenance hemodialysis patients in the HEMO Study.

Su CT, Yabes J, Pike F, Weiner DE, Beddhu S, Burrowes JD, Rocco MV, Unruh ML.

Am J Kidney Dis. 2013 Dec;62(6):1141-50. doi: 10.1053/j.ajkd.2013.05.015. Epub 2013 Jul 13.

PMID:
23859719
16.

The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.

Santoro A, Mancini E, Bolzani R, Boggi R, Cagnoli L, Francioso A, Fusaroli M, Piazza V, Rapanà R, Strippoli GF.

Am J Kidney Dis. 2008 Sep;52(3):507-18. doi: 10.1053/j.ajkd.2008.05.011. Epub 2008 Jul 9.

PMID:
18617304
17.

Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study.

Strippoli GF, Palmer SC, Ruospo M, Natale P, Saglimbene V, Craig JC, Pellegrini F, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Ferrari JN, del Castillo D, Hegbrant J, Wollheim C, Gargano L; ORAL-D Investigators.

BMC Nephrol. 2013 Apr 19;14:90. doi: 10.1186/1471-2369-14-90.

18.

Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study.

Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ; HEMO Study Group.

J Am Soc Nephrol. 2003 Jul;14(7):1863-70.

19.

Relationship of dose of hemodialysis and cause-specific mortality.

Bloembergen WE, Stannard DC, Port FK, Wolfe RA, Pugh JA, Jones CA, Greer JW, Golper TA, Held PJ.

Kidney Int. 1996 Aug;50(2):557-65.

20.

Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis.

Chang TI, Shilane D, Brunelli SM, Cheung AK, Chertow GM, Winkelmayer WC.

Am Heart J. 2011 Aug;162(2):324-30. doi: 10.1016/j.ahj.2011.05.004. Epub 2011 Jul 18.

Supplemental Content

Support Center